Skip to content

G-Probe™ Box of 6 11256Recalls & reported problems

Iridex Corporation · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00851089000227), received between May 5, 2026 and May 5, 2026 — classified as 1 injury.

The most frequently reported specific device problem is “Use of Device Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 1 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Use of Device Problem1

Patient problems

  • Eye Injury1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryMay 5, 2026Use of Device Problem

    IRIDEX RECEIVED A ADVERSE EVENT REPORT INVOLVING A IRIDEX CYCLO G6 AND A G-PROBE DELIVERY DEVICE. AS PER THE REPORT, DURING CILIARY BODY DESTRUCTION USING TSCPC IN CONTINUOUS WAVE, WHICH IS A TREATMENT TO RESOLVE REFRACTORY GLAUCOMA, THE SURGEON REPORTED SCLERAL PERFORATION IN THE PATIENT'S LEFT EYE. IT WAS REPORTED THAT LASER APPLICATION WAS PERFORMED USING TWO ROWS OF TREATMENT SPOTS. A SUTURE WAS USED TO CLOSE THE PERFORATION. THE SURGEON DISCONTINUED THE USE OF THE DELIVERY DEVICE AND OPENED ANOTHER DELIVERY DEVICE AND WAS ABLE TO FINISH THE LASER PROCEDURE. ALTHOUGH, CONJUNCTIVAL AND SCLERAL BURNS ARE KNOWN AND DOCUMENTED COMPLICATIONS OF TSCPC AND TYPICALLY RESOLVE WITHOUT INTERVENTION WITHIN 24 - 48 HOURS, CONJUNCTIVAL AND/OR SCLERAL PERFORATION ARE NOT CONSIDERED A COMMON OCCURRENCE AND MAY REQUIRE MEDICAL INTERVENTION SUCH AS THE USE OF A SUTURE TO MANAGE THE PERFORATION. THE DELIVERY DEVICE IFU WARNS THE USER OF POTENTIAL CONTRIBUTORS TO SCLERAL BURNS RESULTING IN SCLERAL PERFORATION. THE POSSIBLE CONTRIBUTORS INCLUDE (1) EXCESSIVE POWER AND/OR ENERGY DELIVERED, (2) THE PRESENCE OF BLOOD AND/OR TISSUE BENEATH THE DELIVERY DEVICE FOOTPLATE, (3) THE PRESENCE OF PIGMENT OR P

    Patient problems: Eye Injury

    MAUDE report 25087324 ↗

Other Powered Laser Surgical Instrument devices

All Powered Laser Surgical Instrument devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page